Chondrosarcoma — Trials

Chondrosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

73 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 21
Recruiting: 10
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04521686	Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations	active not recruiting	Phase 1	200	Eli Lilly and CompanyINDUSTRY	9	Jul 22, 2026	clinicaltrials
NCT03173976	Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial	active not recruiting	Phase 1	17	Mohammed MilhemOTHER	1	Nov 6, 2025	clinicaltrials